A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Boston Scientific Corporation
Start Date
August 22, 2024
End Date
July 31, 2029
Administered By
Institutes and Centers
Awarded By
Boston Scientific Corporation
Start Date
August 22, 2024
End Date
July 31, 2029